Clalit Health Services, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Acta Derm Venereol. 2010;90(1):23-6. doi: 10.2340/00015555-0741.
In recent years, numerous reports have demonstrated an association between psoriasis and metabolic syndrome. However, some studies failed to demonstrate an association between psoriasis and hypertension. The aim of the present study was to examine the association between psoriasis and hypertension. Psoriasis patients of a health-maintenance organization were compared with enrollees without psoriasis regarding the prevalence of hypertension in a case-control study. The study included 12,502 psoriasis patients over the age of 20 years and 24,285 age- and sex-frequency-matched controls. The prevalence of hypertension was significantly higher in psoriasis patients than controls (38.8%, 29.1%, respectively, p<0.001). In a multivariate analysis, hypertension was associated with psoriasis after controlling for age, sex, smoking status, obesity, diabetes, non-steroidal anti-inflammatory drugs (NSAIDs) and use of Cox-2 inhibitors (odds ratio: 1.37, 95% confidence interval: 1.29-1.46). The results of this study support the previously noted association between psoriasis and hypertension. We suggest that patients with psoriasis should be routinely screened for the presence of hypertension.
近年来,大量报告表明银屑病与代谢综合征之间存在关联。然而,一些研究未能表明银屑病与高血压之间存在关联。本研究旨在探讨银屑病与高血压之间的关系。在一项病例对照研究中,将某一健康维护组织的银屑病患者与无银屑病的参保者进行比较,以评估高血压的患病率。该研究纳入了 12502 名年龄在 20 岁以上的银屑病患者和 24285 名年龄和性别匹配的对照者。银屑病患者的高血压患病率明显高于对照组(分别为 38.8%和 29.1%,p<0.001)。在多变量分析中,在控制年龄、性别、吸烟状况、肥胖、糖尿病、非甾体抗炎药(NSAIDs)和 Cox-2 抑制剂的使用后,高血压与银屑病相关(比值比:1.37,95%置信区间:1.29-1.46)。本研究的结果支持了先前报道的银屑病与高血压之间的关联。我们建议对银屑病患者常规筛查高血压。